IONS vs OPAL · rev $226.6M vs P/E 26, rev $349.0M
Ionis Pharmaceuticals Inc (IONS) versus OPAL Fuels Inc (OPAL) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
OPAL Fuels Inc (OPAL) is a utilities - regulated gas company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported OPAL revenue for 2025-12-31 was $349.0M. Net income was $36.4M. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
IONS currently screens at market cap $12.28B. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
Not investment advice. Open the IONS and OPAL stock pages for the full models.
Not investment advice.